CANnabinoids in Pediatric ONCology is a randomized, double blind, adaptive clinical trial
looking at the tolerability of cannabinoids in children with cancer across 3 Canadian
children's hospitals.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Manitoba
Collaborators:
Canadian Cancer Society (CCS) Canadian Institutes of Health Research (CIHR) The Canadian Collaborative for Childhood Cannabinoid Therapeutics